急性冠脉综合征患者血浆B型钠尿肽的变化及其临床意义-东南大学学报医学版

急性冠脉综合征患者血浆B型钠尿肽的变化及其临床意义

单位：1.江苏省省级机关医院； 2.东南大学附属中大医院,心内科,江苏,南京,210009

分类号：R541.4, R541.6

出版年·卷·期（页码）：2006·25·第五期（373-375）

摘要：

目的:观察急性冠脉综合征(ACS)患者不同情况下血浆B型钠尿肽(BNP)水平,探讨BNP在ACS发病过程中的意义.方法:用免疫荧光快速检测法检测35例ACS患者经皮冠脉介入治疗(PCI)术前、术后24 h血浆BNP水平,并与20例正常对照组血浆BNP水平进行对比.观察和分析ACS患者PCI前血浆BNP水平与心功能及冠状动脉评分(Gensini积分)间的关系.结果:ACS患者入院时血浆BNP水平高于正常对照组(P＜0.001),而介入治疗后BNP水平却明显下降(P=0.027);PCI术前、术后血浆BNP水平急性心肌梗死组均较不稳定心绞痛组高;血浆BNP水平,PCI前LVEF＜50%的明显高于LVEF≥50%患者(P＜0.001),且血浆BNP水平与LVEF呈高度负相关(r=-0.88,P＜0.001),但与Gensini积分无明显相关性(r=0.12,P＞0.05).结论:ACS患者血浆BNP水平明显增高,与患者心力衰竭严重程度相关,介入治疗可使ACS患者血浆BNP水平下降.

Objective To explore the significance of plasma B-type natriuretic peptide(BNP) level in patients with acute coronary syndrome(ACS). Methods Thirty-five patients with ACS and twenty healthy controls were selected into this protocol.Blood samples of ACS patients were extracted from femoral vein on admission immediately and at 24 h after percutaneous coronary intervention(PCI).The plasma BNP was measured by a bedside rapid assay. The plasma level of BNP was compared among those before and after PCI in ACS patients and healthy controls with different conditions of heart function.The relationship of BNP and Gensini scores was studied by correlation analysis.Results The plasma level of BNP was significantly increased in patients with ACS compared with that in the control subjects(P<(0.001)),but BNP level was decreased after PCI(P=0.027).Plasma BNP was significantly increased in ACS patients with a LVEF<50% than in those with a LVEF≥50%(P<0.001),and it was negatively correlated with LVEF(r=(-0.88),P<0.001),but there was no significant relationship between Gensini scores and the plasma BNP in ACS group(r=(0.12,) P>0.05).Conclusion Plasma level of BNP increased significantly in ACS patients is correlated with classification of heart function,which can be decreased by percutaneous coronary intervention.

参考文献：

[1] GENSINI G G. A more meaningful scoreing system for determing the severity of coronary heart disease, 1983(3)
[2] SUZUKI T, YAMAZAKI T, YAZAKI Y. The role of the natriuretic peptides in the cardiovascular system. 2001(3). doi:10.1016/S0008-6363(1)00238-3
[3] MORITA E, YASUE H, YOSHIMURA M. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction, 1993(1)
[4] MORROW D A, de LEMOS J A, SABATINE M S. Evaluation of B-type natriuretic peptide for risk assessment in unstable anginay non-ST-elevation myocardial infarction:B -type natriuretic peptide and prognosis in TACTICS-TIMI 18. 2003(10). doi:10.1016/S0735-1097(3)00168-2
[5] KYRIAKIDES Z S, MARKIANOS M, MICHALIS L. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. 2000(4). doi:10.1002/clc.4960230412
[6] TATEISHI J, MASUTANI M, OHYANAGI M. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. 2000(10). doi:10.1002/clc.4960231016
[7] MUKOYAMA M, NAKAO K, HOSODA K. Brain natriuretic peptide as a novel cardic hormone in humans:Evidence for an exquisite dual natriuretic peptide system.Atrial natriuretic peptide and brain natriuretic peptide, 1991(4)

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录